Cian Healthcare Ltd: Intrinsic Value & Share Price Analysis

Q: What is the current share price and 52-week range of Cian Healthcare Ltd?

Cian Healthcare Ltd is trading at 8.26 as of 28 April 2026, with a FY2026-2027 high of 8.26 and low of 3.07. The stock is currently near its 52-week high. Market cap stands at 20.6 Cr..

Q: Is Cian Healthcare Ltd financially healthy?

Key indicators: ROCE of 10.6 % is moderate. Dividend yield is 0.00 %.

Q: Is Cian Healthcare Ltd profitable and how is the profit trend?

Cian Healthcare Ltd reported a net profit of -26 Cr in Mar 2025 on revenue of 31 Cr. Compared to -6 Cr in Mar 2022, the net profit shows a mixed trend.

Fair Value

₹48.21Undervalued by 483.66%vs CMP ₹8.26

P/E (15.0) × ROE (30.3%) × BV (₹13.00) × DY (2.00%)

Defaults: P/E=15

₹20.49Undervalued by 148.06%vs CMP ₹8.26

MoS: +59.7% (Strong)Confidence: 44/100 (Low)Models: 3 Under, 1 Over

Model	Category	Value	Weight	Signal
PE-ROE	Earnings	₹29.63	41%	Under (+258.7%)
Net Asset Value	Assets	₹12.83	24%	Under (+55.3%)
ROCE Capital	Returns	₹25.17	16%	Under (+204.7%)
Revenue Multiple	Revenue	₹6.22	18%	Over (-24.7%)
Consensus (4 models)		₹20.49	100%	Undervalued

Key Drivers: EPS CAGR -38.5% drags value — could be higher if earnings stabilize. | Wide model spread (₹6–₹30) — high uncertainty.

PE-ROE · Graham · EPV · DCF · NAV · EV/EBITDA · DDM · Earnings Yield · ROCE Capital · Revenue Multiple | CoE: 12% · Terminal: 4% · EPS CAGR: -38.5% · Defaults: P/E=15

*Investments are subject to market risks

Analyst Summary

Cian Healthcare Ltd operates in the Pharmaceuticals segment, NSE: CHCL | BSE: 542678, current market price is ₹8.26, market cap is 20.6 Cr.. At a glance, ROE is 30.3 %, ROCE is 10.6 %, book value is 13.0, dividend yield is 0.00 %. The latest intrinsic value estimate is ₹20.49, which is about 148.1% above the current price, so the page currently reads as potentially undervalued rather than fully priced. On operating trend, latest reported sales are about ₹31 Cr versus the prior period change of -50.0%, while latest net profit is about ₹-26 Cr with a prior-period change of -2,700.0%. The 52-week range shown on this page is 8.26/3.07, which helps frame where the current quote sits within its recent trading band. Business context: About the Company - Qualitative AnalysisCian Healthcare Ltd. is a Public Limited Listed company incorporated on 07/01/2003 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L…

This summary is generated from the stock page data available for Cian Healthcare Ltd: Intrinsic Value & Share Price Analysis and is refreshed automatically when the underlying metrics change.

Investment Snapshot

Cian Healthcare Ltd scores 47/100 (Average)

Based on 5 dimensions: health, institutional flow, earnings quality, momentum, and peer comparison

Stock Health44/100 · Moderate

ROCE 10.6% AverageROE 30.3% ExcellentD/E 1.22 High debtInterest Coverage 0.0x RiskyProfitable 2/5 years Inconsistent

Smart Money60/100 · Moderate

Promoter increased by 67.89% Positive

Earnings Quality50/100 · Moderate

OPM contracting (13% → -2%) DecliningWorking capital: 26 days (improving) Efficient

Quarterly Momentum40/100 · Moderate

Revenue (4Q): -4% YoY FlatOPM: -8.0% (down 22.0% YoY) Margin pressure

Industry Rank50/100 · Moderate

ROCE 10.6% vs industry 16.4% AverageROE 30.3% vs industry 15.2% Above peers3Y sales CAGR: -26% Shrinking

Weights: Health 30% · Earnings Quality 25% · Momentum 20% · Industry Rank 15% · Smart Money 10%. Scores are computed from reported financials and recalculated daily. Not investment advice.

Share Price and Basic Stock Data

Last Updated: April 26, 2026, 1:16 am

Market Cap	20.6 Cr.
Current Price	8.26
Intrinsic Value	₹20.49
High / Low	8.26/3.07
Stock P/E
Book Value	13.0
Dividend Yield	0.00 %
ROCE	10.6 %
ROE	30.3 %
Face Value	10.0
PEG Ratio	0.00

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Cian Healthcare Ltd

Competitors

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
Lactose (India) Ltd	142 Cr.	113	137/76.0	29.4	49.6	0.00 %	12.9 %	9.69 %	10.0
MPS Pharmaa Ltd	3.31 Cr.	1.73	3.15/1.57		0.33	0.00 %	9.79 %	59.0 %	10.0
Gujarat Themis Biosyn Ltd	3,922 Cr.	360	479/225	82.1	24.3	0.19 %	27.3 %	21.7 %	1.00
Gujarat Terce Laboratories Ltd	29.4 Cr.	37.8	68.4/29.0		10.1	0.00 %	41.4 %	14.6 %	10.0
Gujarat Inject (Kerala) Ltd	140 Cr.	95.5	95.9/17.0	560	6.93	0.00 %	13.5 %	11.0 %	10.0
Industry Average	19,737.15 Cr	1,103.08		59.48	201.13	0.36%	16.35%	15.16%	6.10

All Competitor Stocks of Cian Healthcare Ltd

Quarterly Result

Metric	Sep 2019	Mar 2020	Sep 2020	Mar 2021	Sep 2021	Mar 2022	Sep 2022	Mar 2023	Sep 2023	Mar 2024	Sep 2024
Sales	29	28	39	35	47	31	38	31	33	62	19
Expenses	26	23	34	28	44	30	32	24	28	51	20
Operating Profit	3	4	5	7	3	1	5	7	4	11	-1
OPM %	10%	15%	13%	20%	7%	3%	14%	22%	14%	18%	-8%
Other Income	0	1	-0	0	0	0	1	0	0	0	-12
Interest	4	4	4	4	3	3	3	3	3	6	2
Depreciation	2	3	2	1	2	2	3	3	3	5	2
Profit before tax	-2	-2	-1	2	-2	-4	0	2	-1	0	-18
Tax %	0%	17%	23%	28%	7%	-13%	-167%	14%	37%	-400%	0%
Net Profit	-2	-2	-1	1	-2	-4	0	2	-1	0	-18
EPS in Rs	-0.86	-0.75	-0.46	0.48	-0.72	-1.54	0.19	0.62	-0.59	0.10	-7.30

Last Updated: December 27, 2025, 1:32 pm

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 27, 2026, 2:30 am

Metric	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Sales	57	74	78	69	62	31
Expenses	50	62	74	56	51	37
Operating Profit	7	12	4	13	11	-7
OPM %	13%	16%	6%	19%	18%	-21%
Other Income	1	0	0	1	0	-12
Interest	7	8	7	6	6	3
Depreciation	4	3	4	5	5	4
Profit before tax	-4	1	-6	2	0	-26
Tax %	7%	91%	-8%	-2%	-1,600%	-0%
Net Profit	-4	0	-6	2	1	-26
EPS in Rs	-1.62	0.02	-2.21	0.81	0.34	-10.39
Dividend Payout %	-0%	-0%	-0%	-0%	-0%	-0%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2020-2021	2022-2023	2023-2024	2024-2025
YoY Net Profit Growth (%)	100.00%	133.33%	-50.00%	-2700.00%
Change in YoY Net Profit Growth (%)	0.00%	33.33%	-183.33%	-2650.00%

Cian Healthcare Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 4 years from 2020-2021 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:	%
5 Years:	%
3 Years:	-6%
TTM:	27%

Compounded Profit Growth
10 Years:	%
5 Years:	%
3 Years:	53%
TTM:	-8600%

Stock Price CAGR
10 Years:	%
5 Years:	-25%
3 Years:	-43%
1 Year:	-49%

Return on Equity
10 Years:	%
5 Years:	%
3 Years:	-2%
Last Year:	0%

Last Updated: September 5, 2025, 2:56 pm

Balance Sheet

Last Updated: December 4, 2025, 2:38 am

Month	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	23	23	25	25	25	25
Reserves	35	35	30	32	33	7
Borrowings	73	71	63	61	56	55
Other Liabilities	25	28	47	42	47	69
Total Liabilities	157	157	166	160	161	156
Fixed Assets	39	37	50	45	39	35
CWIP	25	26	13	14	15	15
Investments	5	5	5	5	5	5
Other Assets	87	90	98	97	102	101
Total Assets	157	157	166	160	161	156

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity +	-7	6	9	5	12	21
Cash from Investing Activity +	-27	3	1	3	-1	-0
Cash from Financing Activity +	36	-10	-11	-7	-10	-4
Net Cash Flow	1	-1	-1	-0	-0	17
Free Cash Flow	-26	4	4	4	11	20
CFO/OP	-99%	49%	197%	37%	106%	-315%

Free Cash Flow

Month	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Free Cash Flow	-66.00	-59.00	-59.00	-48.00	-45.00	-62.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	127.80	93.56	125.24	139.58	121.15
Inventory Days	267.18	312.78	299.94	399.93	485.99
Days Payable	220.03	209.37	270.46	295.80	371.29
Cash Conversion Cycle	174.95	196.98	154.73	243.71	235.85
Working Capital Days	14.77	16.14	38.30	40.66	26.27
ROCE %		6.78%	0.50%	6.91%	5.22%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Dec 2021	Mar 2022	Sep 2022	Dec 2022	Mar 2023	Sep 2023	Mar 2024	Jun 2024	Sep 2024	Mar 2025	Sep 2025	Jan 2026
Promoters	66.26%	66.26%	66.26%	66.26%	51.85%	49.62%	27.10%	27.10%	27.11%	27.11%	27.11%	95.00%
DIIs	0.00%	0.00%	0.00%	0.79%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Public	33.74%	33.74%	33.75%	32.96%	48.16%	50.39%	72.90%	72.90%	72.90%	72.89%	72.89%	5.01%
No. of Shareholders	396	392	424	418	454	672	880	831	1,088	1,501	1,662	1,699

Shareholding Pattern Chart

No. of Shareholders

Cian Healthcare Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

This stock is not held by any mutual fund.

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
FaceValue	10.00	10.00	10.00	10.00	10.00
Basic EPS (Rs.)	-10.39	0.10	0.81	-2.32	0.02
Diluted EPS (Rs.)	-10.39	0.10	0.81	-2.32	0.02
Cash EPS (Rs.)	-8.63	2.29	2.98	-0.50	1.50
Book Value[Excl.RevalReserv]/Share (Rs.)	12.95	23.10	23.00	22.19	24.92
Book Value[Incl.RevalReserv]/Share (Rs.)	12.95	23.10	23.00	22.19	24.93
Revenue From Operations / Share (Rs.)	12.32	24.68	27.44	31.15	31.56
PBDIT / Share (Rs.)	-2.57	4.52	5.20	1.91	5.17
PBIT / Share (Rs.)	-4.33	2.34	3.03	0.20	3.69
PBT / Share (Rs.)	-10.40	0.01	0.79	-2.37	0.38
Net Profit / Share (Rs.)	-10.39	0.10	0.81	-2.21	0.02
NP After MI And SOA / Share (Rs.)	-10.39	0.10	0.81	-2.21	0.02
PBDIT Margin (%)	-20.89	18.32	18.94	6.14	16.37
PBIT Margin (%)	-35.15	9.46	11.03	0.65	11.69
PBT Margin (%)	-84.40	0.07	2.90	-7.61	1.21
Net Profit Margin (%)	-84.34	0.41	2.95	-7.10	0.07
NP After MI And SOA Margin (%)	-84.34	0.41	2.95	-7.10	0.07
Return on Networth / Equity (%)	-80.28	0.44	3.53	-9.97	0.09
Return on Capital Employeed (%)	-26.04	6.14	7.94	0.53	8.66
Return On Assets (%)	-16.64	0.15	1.26	-3.33	0.03
Long Term Debt / Equity (X)	0.21	0.47	0.51	0.68	0.64
Total Debt / Equity (X)	1.70	0.96	1.06	1.14	1.22
Asset Turnover Ratio (%)	0.19	0.38	0.44	0.43	0.49
Current Ratio (X)	0.61	1.09	1.14	1.14	1.10
Quick Ratio (X)	0.39	0.46	0.57	0.56	0.56
Inventory Turnover Ratio (X)	0.91	1.59	0.96	1.24	1.54
Interest Coverage Ratio (X)	-2.21	1.95	2.28	0.74	1.56
Interest Coverage Ratio (Post Tax) (X)	-3.71	1.04	1.34	0.15	1.03
Enterprise Value (Cr.)	45.84	106.16	129.47	109.32	94.69
EV / Net Operating Revenue (X)	1.49	1.72	1.89	1.40	1.28
EV / EBITDA (X)	-7.12	9.39	9.96	22.84	7.84
MarketCap / Net Operating Revenue (X)	0.27	0.83	1.02	0.61	0.35
Price / BV (X)	0.26	0.89	1.22	0.85	0.45
Price / Net Operating Revenue (X)	0.28	0.83	1.02	0.61	0.35
EarningsYield	-3.01	0.00	0.02	-0.11	0.00

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

About the Company - Qualitative Analysis

Cian Healthcare Ltd. is a Public Limited Listed company incorporated on 07/01/2003 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24233PN2003PLC017563 and registration number is 017563. Currently Company is involved in the business activities of Manufacture of `ayurvedic' or `unani' pharmaceutical preparation. Company's Total Operating Revenue is Rs. 30.88 Cr. and Equity Capital is Rs. 25.00 Cr. for the Year ended 31/03/2025.

INDUSTRY	ADDRESS	CONTACT
Pharmaceuticals	Office No 301, 3rd Floor, Konark Icon, Mundhwa Kharadi Road, Magarpatta, Hadapsar, Pune Maharashtra 411028	Contact not found

Management
Name	Position Held
Mr. Suraj Shriniwas Zanwar	Managing Director
Mr. Sunil Kumar	Independent Director
Mr. Santosh Shivaji Pimparkar	Independent Director

FAQ

What is the intrinsic value of Cian Healthcare Ltd and is it undervalued?

As of 28 April 2026, Cian Healthcare Ltd's intrinsic value is ₹20.49, which is 148.06% higher than the current market price of ₹8.26, suggesting the stock is undervalued. This is calculated using the PE ratio method factoring in ROE (30.3 %), book value (₹13.0), dividend yield (0.00 %), and 5-year EPS CAGR.

What is the current share price and 52-week range of Cian Healthcare Ltd?

Cian Healthcare Ltd is trading at ₹8.26 as of 28 April 2026, with a FY2026-2027 high of ₹8.26 and low of ₹3.07. The stock is currently near its 52-week high. Market cap stands at ₹20.6 Cr..

How does Cian Healthcare Ltd's P/E ratio compare to its industry?

Cian Healthcare Ltd has a P/E ratio of , which is below the industry average of 59.48. This is broadly in line with or below the industry average.

Is Cian Healthcare Ltd financially healthy?

Key indicators for Cian Healthcare Ltd: ROCE of 10.6 % is moderate; ROE of 30.3 % shows strong shareholder returns. Dividend yield is 0.00 %.

Is Cian Healthcare Ltd profitable and how is the profit trend?

Cian Healthcare Ltd reported a net profit of ₹-26 Cr in Mar 2025 on revenue of ₹31 Cr. Compared to ₹-6 Cr in Mar 2022, the net profit shows a mixed trend.

Does Cian Healthcare Ltd pay dividends?

Cian Healthcare Ltd has a dividend yield of 0.00 % at the current price of ₹8.26. The company is currently not paying meaningful dividends.